Delivery Order SPE2DB22D9206-SPE2DB24FV5FA

Award Date 8/15/24
Potential Completion Date 9/6/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, and has a ceiling value of $17,152.56. The contract is a firm fixed-price delivery order with no set-aside designation, and the ultimate completion date is September 24, 2024. The contract is part of a larger...
This is a $12,307.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560 units of the NEXPLANON 68 MG IMPLANTS contraceptive device, with a period of performance through March 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $37,750.80, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The delivery order was issued under an Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract has a ceiling value of $15,729.50 and covers the procurement of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $57,175.20, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a ceiling value of $2,144.07 and a period of performance through August 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 contract is for the delivery of 68 mg NEXPLANON implants, a contraceptive device. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $88,554.24 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, to the DLA. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,576.28, is for the delivery of NEXPLANON 68 MG implants, a contraceptive product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to $499,999,999, which runs through December 31, 2025. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a type of contraceptive product. The contract has a firm-fixed-price pricing structure and a ceiling value of $2,858.76. The period of performance runs through July 17, 2024. This delivery order is issued under a larger indefinite...
  • SPE2DB22D9206
    Indefinite Delivery Contract
  • SPE2DB22D9206-SPE2DB24FV5FA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $25,728.84. The contract is a firm fixed-price delivery order with no set-aside designation, and has an ultimate completion date of September 6, 2024. This contract is part of a larger indefinite delivery contract (IDC) vehicle with the DLA under the SPE2DB program, which has a potential value of up to $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, including both common medications and specialized drugs, to support the medical supply needs of various Department of Defense healthcare facilities worldwide.

Generated 11/14/24, 9:11 AM